Cytek Biosciences, Inc.

$3.77+5.60%(+$0.20)
TickerSpark Score
51/100
Mixed
85
Valuation
40
Profitability
25
Growth
76
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTKB research report →

52-Week Range37% of range
Low $2.37
Current $3.77
High $6.18

Companycytekbio.com

Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis.

CEO
Wenbin Jiang
IPO
2021
Employees
663
HQ
Fremont, CA, US

Price Chart

+41.73% · this period
$5.88$4.15$2.42May 20Nov 18May 20

Valuation

Market Cap
$486.87M
P/E
-6.56
P/S
2.38
P/B
1.48
EV/EBITDA
-19.47
Div Yield
0.00%

Profitability

Gross Margin
51.70%
Op Margin
-21.49%
Net Margin
-36.25%
ROE
-20.77%
ROIC
-11.42%

Growth & Income

Revenue
$201.49M · 0.52%
Net Income
$-66,539,000 · -1005.30%
EPS
$-0.52 · -1030.43%
Op Income
$-40,384,000
FCF YoY
-140.13%

Performance & Tape

52W High
$6.18
52W Low
$2.37
50D MA
$4.39
200D MA
$4.48
Beta
1.23
Avg Volume
792.28K

Get TickerSpark's AI analysis on CTKB

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 13, 26Yan Mingother1,176,000
Mar 10, 26Chin Richardother6,107
Mar 10, 26Chin Richardother6,107
Mar 10, 26Barnett Valerieother226,453
Mar 10, 26Barnett Valerieother14,501
Mar 10, 26Barnett Valerieother5,740
Mar 10, 26Barnett Valerieother14,501
Mar 10, 26Barnett Valerieother10,313
Mar 10, 26Barnett Valerieother4,247
Mar 10, 26Barnett Valerieother4,908

Our CTKB Coverage

We haven't published any research on CTKB yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CTKB Report →

Similar Companies